Literature DB >> 20419352

Blue moon neurovirology: the merits of studying rare CNS diseases of viral origin.

Lauren A O'Donnell1, Glenn F Rall.   

Abstract

While measles virus (MV) continues to have a significant impact on human health, causing 150,000-200,000 deaths worldwide each year, the number of fatalities that can be attributed to MV-triggered central nervous system (CNS) diseases are on the order of a few hundred individuals annually (World Health Organization 2009). Despite this modest impact, substantial effort has been expended to understand the basis of measles-triggered neuropathogenesis. What can be gained by studying such a rare condition? Simply stated, the wealth of studies in this field have revealed core principles that are relevant to multiple neurotropic pathogens, and that inform the broader field of viral pathogenesis. In recent years, the emergence of powerful in vitro systems, novel animal models, and reverse genetics has enabled insights into the basis of MV persistence, the complexity of MV interactions with neurons and the immune system, and the role of immune and CNS development in virus-triggered disease. In this review, we highlight some key advances, link relevant measles-based studies to the broader disciplines of neurovirology and viral pathogenesis, and propose future areas of study for the field of measles-mediated neurological disease.

Entities:  

Mesh:

Year:  2010        PMID: 20419352     DOI: 10.1007/s11481-010-9200-4

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   7.285


  101 in total

Review 1.  Altruistic cell suicide and the specialized case of the virus-infected nervous system.

Authors:  T E Allsopp; J K Fazakerley
Journal:  Trends Neurosci       Date:  2000-07       Impact factor: 13.837

Review 2.  Neonatal adaptive immunity comes of age.

Authors:  Becky Adkins; Claude Leclerc; Stuart Marshall-Clarke
Journal:  Nat Rev Immunol       Date:  2004-07       Impact factor: 53.106

3.  Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS.

Authors:  M M Berger; N Kopp; C Vital; B Redl; M Aymard; B Lina
Journal:  Neurology       Date:  2000-01-11       Impact factor: 9.910

4.  Immune activation during measles: interferon-gamma and neopterin in plasma and cerebrospinal fluid in complicated and uncomplicated disease.

Authors:  D E Griffin; B J Ward; E Jauregui; R T Johnson; A Vaisberg
Journal:  J Infect Dis       Date:  1990-03       Impact factor: 5.226

5.  Quantification of neurometabolites in subacute sclerosing panencephalitis by 1H-MRS.

Authors:  K Aydin; B Tatli; M Ozkan; K Ciftci; Z Unal; S Sani; M Ozmen; M Caliskan; N Aydinli; S Guven
Journal:  Neurology       Date:  2006-09-12       Impact factor: 9.910

6.  Differential permissivity to measles virus infection of human and CD46-transgenic murine lymphocytes.

Authors:  Alexey Evlashev; Hélène Valentin; Pierre Rivailler; Olga Azocar; Chantal Rabourdin-Combe; Branka Horvat
Journal:  J Gen Virol       Date:  2001-09       Impact factor: 3.891

7.  Evidence that the hypermutated M protein of a subacute sclerosing panencephalitis measles virus actively contributes to the chronic progressive CNS disease.

Authors:  J B Patterson; T I Cornu; J Redwine; S Dales; H Lewicki; A Holz; D Thomas; M A Billeter; M B Oldstone
Journal:  Virology       Date:  2001-12-20       Impact factor: 3.616

8.  A transgenic mouse model for measles virus infection of the brain.

Authors:  G F Rall; M Manchester; L R Daniels; E M Callahan; A R Belman; M B Oldstone
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

9.  Persistent measles virus infection of mouse neural cells lacking known human entry receptors.

Authors:  H Abdullah; J A P Earle; T A Gardiner; F Tangy; S L Cosby
Journal:  Neuropathol Appl Neurobiol       Date:  2009-10       Impact factor: 8.090

10.  Update: measles--United States, January-July 2008.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-08-22       Impact factor: 17.586

View more
  15 in total

1.  Ifit2 Is a Restriction Factor in Rabies Virus Pathogenicity.

Authors:  Benjamin M Davis; Volker Fensterl; Tessa M Lawrence; Andrew W Hudacek; Ganes C Sen; Matthias J Schnell
Journal:  J Virol       Date:  2017-08-10       Impact factor: 5.103

2.  In Vivo Efficacy of Measles Virus Fusion Protein-Derived Peptides Is Modulated by the Properties of Self-Assembly and Membrane Residence.

Authors:  T N Figueira; L M Palermo; A S Veiga; D Huey; C A Alabi; N C Santos; J C Welsch; C Mathieu; B Horvat; S Niewiesk; A Moscona; M A R B Castanho; M Porotto
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

3.  HCV: Written in our DNA.

Authors:  Darja Kanduc
Journal:  Self Nonself       Date:  2011-04-01

4.  Prevention of measles virus infection by intranasal delivery of fusion inhibitor peptides.

Authors:  C Mathieu; D Huey; E Jurgens; J C Welsch; I DeVito; A Talekar; B Horvat; S Niewiesk; A Moscona; M Porotto
Journal:  J Virol       Date:  2014-11-05       Impact factor: 5.103

5.  Measles Virus Bearing Measles Inclusion Body Encephalitis-Derived Fusion Protein Is Pathogenic after Infection via the Respiratory Route.

Authors:  Cyrille Mathieu; Marion Ferren; Eric Jurgens; Claire Dumont; Ksenia Rybkina; Olivia Harder; Debora Stelitano; Silvia Madeddu; Giuseppina Sanna; Dayna Schwartz; Sudipta Biswas; Diana Hardie; Takao Hashiguchi; Anne Moscona; Branka Horvat; Stefan Niewiesk; Matteo Porotto
Journal:  J Virol       Date:  2019-04-03       Impact factor: 5.103

Review 6.  Everything You Always Wanted to Know About Rabies Virus (But Were Afraid to Ask).

Authors:  Benjamin M Davis; Glenn F Rall; Matthias J Schnell
Journal:  Annu Rev Virol       Date:  2015-06-24       Impact factor: 10.431

7.  CD4+ T cells require either B cells or CD8+ T cells to control spread and pathogenesis of a neurotropic infection.

Authors:  Andreas C Solomos; Kevin J O'Regan; Glenn F Rall
Journal:  Virology       Date:  2016-09-24       Impact factor: 3.616

8.  Fatal measles virus infection prevented by brain-penetrant fusion inhibitors.

Authors:  Jeremy C Welsch; Aparna Talekar; Cyrille Mathieu; Antonello Pessi; Anne Moscona; Branka Horvat; Matteo Porotto
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

9.  Measles fusion machinery is dysregulated in neuropathogenic variants.

Authors:  Eric M Jurgens; Cyrille Mathieu; Laura M Palermo; Diana Hardie; Branka Horvat; Anne Moscona; Matteo Porotto
Journal:  mBio       Date:  2015-02-10       Impact factor: 7.867

10.  Viral infections of the central nervous system: pathogenesis to therapeutics.

Authors:  Samantha S Soldan; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2010-07-24       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.